(EMAILWIRE.COM, March 15, 2021 ) AUSTIN, Texas and DUBAI, UAE -- Nano Cures Inc. (“Nano”), a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management,...more
